| 000 | 01064nam a22002897a 4500 | ||
|---|---|---|---|
| 001 | 06216 | ||
| 003 | HDC | ||
| 007 | cr bn ---aaaaa | ||
| 008 | 210123b20052005xxu||||| |||| 00| 0 eng d | ||
| 020 | _a0824754603 | ||
| 040 | _aHDC | ||
| 100 |
_aCohen, Edward M. _eauthor _96540 |
||
| 245 | 0 |
_aActive pharmaceutical ingredients _c/ Edward M. Cohen, Lih-Yang Lin |
|
| 260 |
_aNew York: _bMarcel Dekker, _c2005 |
||
| 300 | _a1 online resource (13 pages) | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 500 |
_aOriginally from: Generic drug product development : solid oral dosage forms, 2005 _aIncludes bibliographical references |
||
| 650 |
_aDrugs _xTesting _94535 |
||
| 650 |
_aPharmaceutical industry _9799 |
||
| 700 |
_aLin, Lih-Yang _ejoint author _96541 |
||
| 856 | _zRequest full-text at [email protected] | ||
| 942 | _2lcc | ||
| 942 | _cCHAP | ||
| 942 | _kEBCH 004235 | ||
| 999 |
_c3540 _d3540 |
||